Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives
Omkulthom Al Kamaly, Najla Altwaijry, Rehab Sabour, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 4
Closed Access | Times Cited: 17

Showing 17 citing articles:

Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 68
Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
Esraa A. Abdelsalam, Amer Ali Abd El‐Hafeez, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2265-2282
Open Access | Times Cited: 31
Synthetic Approaches, Biological Activities, and Structure–Activity Relationship of Pyrazolines and Related Derivatives
Rajnish Kumar, Himanshu Singh, Avijit Mazumder, et al.
Topics in Current Chemistry (2023) Vol. 381, Iss. 3
Closed Access | Times Cited: 15
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 8
Antiproliferative Potential of Dypsis decaryi Seeds Supported by Metabolic Profiling and Molecular Docking
Marwa Hassan Hussaen Mohammed, Ashraf Hamed, Ahmed M. Sayed, et al.
Journal of Herbal Medicine (2024) Vol. 44, pp. 100846-100846
Closed Access | Times Cited: 2
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 2
A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells
Mustofa, Pamungkas Bagus Satriyo, Artania Adnin Tri Suma, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2325-2339
Open Access | Times Cited: 11
Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer
Megha Jethwa, Aditi Gangopadhyay, Achintya Saha
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100143-100143
Open Access | Times Cited: 1
Recent Advances in Nanocatalyzed One-Pot Sustainable Synthesis of Bioactive N, N-Heterocycles with Anticancer Activities: An Outlook of Medicinal Chemistry
Sasadhar Majhi
Current Topics in Medicinal Chemistry (2024) Vol. 25, Iss. 1, pp. 63-95
Closed Access | Times Cited: 1
Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition
Bing Yang, Jiahua Zhou, Fa Wang, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105134-105134
Closed Access | Times Cited: 10
New pyridine‐based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities
Jonathan Ramírez–Prada, Juan S. Rocha‐Ortiz, Marta I. Orozco, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access
Application of a Deep Eutectic Solvent for the Synthesis of Novel Imidazole-Containing Quinazoline Derivatives as Potent Cytotoxic Agents
Fatemeh Azmian Moghadam, Sara Dabirian, Amin Ebrahimi Tavani, et al.
Pharmaceutical Sciences (2024) Vol. 30, Iss. 2, pp. 215-228
Open Access
Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives
Javier Maldonado, Alfonso Oliva, Leda Guzmán, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7281-7281
Open Access
Efficient One-Pot Synthesis of Pyrazole–Pyrazol-3-one Hybrid Analogs and Evaluation of Their Antimicrobial Activity
T. Sivaganesh, P. Padmaja, Pedavenkatagari Narayana Reddy
Russian Journal of Organic Chemistry (2022) Vol. 58, Iss. 1, pp. 81-86
Closed Access | Times Cited: 2
Synthesis, Molecular Docking, and ADMET Study of N1-Hydrogen and N1-Benzoyl Pyrazoline as Antibacterial Agents
Putra Jiwamurwa Pama Tjitda, Jumina Jumina, Tutik Dwi Wahyuningsih
Chiang Mai University Journal of Natural Sciences (2022) Vol. 21, Iss. 3
Open Access | Times Cited: 2
Discovery of New Quinoxalines as Cytotoxic Agents: Design, Synthesis and Molecular Modeling
Rabab Ibrahim, Magda M. F. Ismail, Taghreed Z. Shawer, et al.
Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences (2023) Vol. 3, Iss. 2, pp. 119-132
Open Access
Synthetic Strategies of Pyrazoline Derivatives for the Development of New Anticancer Agents: Recent Updates
Pushkar Kumar Ray, Salahuddin Salahuddin, Avijit Mazumder, et al.
Mini-Reviews in Organic Chemistry (2022) Vol. 21, Iss. 1, pp. 92-132
Closed Access
Page 1

Scroll to top